End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 THB | +1.85% |
|
+4.76% | +22.91% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With a 2024 P/E ratio at 27 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.91% | 791M | - | ||
-33.75% | 13.7B | B+ | ||
+4.15% | 11.72B | B+ | ||
-2.70% | 11.51B | B | ||
+8.56% | 10.56B | B+ | ||
+28.69% | 8.52B | B | ||
-10.32% | 7.09B | A- | ||
+7.69% | 6.81B | B- | ||
+8.41% | 6.48B | D | ||
0.00% | 4.89B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- VIBHA Stock
- Ratings Vibhavadi Medical Center